BioPharm International
May 15, 2002
Columns and Departments
15
5
by Charles Lambalot, Millipore Corporation
May 15, 2002
Columns and Departments
15
5
by Suzanne Mattingly, Scimagix, Inc.
May 15, 2002
Columns and Departments
15
5
by Benjamin H. Rudolph, Aptgen, Inc. What's an investor to do when previously rock-solid investments suddenly aren't?
May 15, 2002
Columns and Departments
15
5
by Jill Wechsler Bioterrorism and common infections create challenges for manufacturers.
May 15, 2002
Columns and Departments
15
5
by Jim Miller, and Edward P. Miller, PharmSource Informaton Services, Inc. Today, reverse auctions are perceived more realistically than in years past, but they still offer many benefits for both buyer and seller.
May 15, 2002
Columns and Departments
15
5
by John E. McEntire Is your company gambling with analytical mehods and with your product's future? Play validation bingo and find out.
May 15, 2002
Columns and Departments
15
5
by Lorna D. McLeod, BioPharm A network of resources and infrastructure facilitates the high-tech business actively courted and encouraged by the Commonwealth of Virginia.
May 15, 2002
15
5
by Narinder K. Mehta, Javier Goenaga-Polo, Samuel P. Hernandez-Rivera, David Hernandez, Peter J. Melling, and Mary A. Thomson, Remspec Corporation A fiber-optic, mid-IR spectroscopy probe combined with a grazing-angle reflectance sampling head can be used as a solvent-free in situ method for validating cleanliness with substantial improvement in accuracy.
May 15, 2002
15
5
by Timothy N. Breece, and Charles Schmelzer, Genentech, Inc. FDA requires chromatography procedures to be validated for reuse, cleanability, sanitization, robustness, and (potentially) for virus removal. This case study follows the development of a validation process that combines reuse and characterization studies, defines acceptable running parameters, reduces costs, and meets GMP requirements.
May 15, 2002
15
5
by Serena Donnelly Webb, David F. Sesin, Aimee C. Kincaid, Jonathan N. Webb, and Timothy G. Hughes, Integrated Biosystems, Inc. Large-scale freezing and thawing is commonly used in biopharmaceutical manufacturing but is not well understood. Freeze-thaw variations can exist within or between batches, and nonuniform processes raise serious validation concerns.
April 15, 2002
Columns and Departments
15
5
by Mark Wysong, Dolphin Software